ENG and COVID-19: In the 9 ascertained COVID-19 patients, the HHT-causing mutation was located in the ENG gene (HHT1) and in the ALK1/ACVRL1 gene (HHT2) in 3 and 6 patients, respectively, thus resulting in an overlapping distribution with the COVID-19-free patients.